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due to Streptococcus dysgalactiae subsp.
equisimilis (group C or G streptococci)
Sari Rantala1* and Suvi Tuohinen2Abstract
Background: Cardiac device-related endocarditis is a very rare clinical manifestation of S. dysgalactiae subsp.
equisimilis disease. This pathogen is a common cause of cellulitis. We here report two cases of cardiac device-related
endocarditis due to Streptococcus dysgalactiae subsp. equisimilis. Blood cultures yielded this pathogen and both patients
had recurrent bacteremia. Transthoracic and transesophageal echocardiography revealed lead vegetations. This is a
new description of this pathogen to cause cardiac device-related endocarditis.
Case presentation: The first case is a 79-year-old finnish woman who received a dual-chamber pacemaker for
intermittent complete heart block in April 2011. She had three episodes of S. dysgalactiae subsp. equisimilis
bacteremia. During first episode she had arthritis of glenohumeral joint. Focus was unknown in the second and
third bacteremic episodes. During third bacteremic episode transesophageal echocardiography (TEE) revealed
lead vegetation. Patient underwent successful complete system removal. She was treated with benzylpenicillin four
million IU six times a day for four weeks intravenously. The second case is a 92-year-old finnish man. A dual-chamber
pacemaker was implanted on June 2012 due to total heart block. He had recurrent S. dysgalactiae subsp. equisimilis
bacteremia with cellulitis. During the second bacteremic episode transthoracic echocardiography (TTE) was performed
because of persistent fever. Echocardiography revealed lead vegetation. Abdominal CT revealed also an abscess in the
psoas region. This elderly patient was very fragile, and the pacemaker system was not extracted. Therapy was continued
with benzylpenicillin four million IU six times a day for six weeks intravenously and thereafter suppressive treatment
with amoksisillin 500 mg three times a day was initiated.
Conclusion: Streptococcus dysgalactiae subsp. equisimilis (group C and G streptococci) seldom cause cardiac device
endocarditis. Both patients had recurrent bacteremia of S. dysgalactiae subsp. equisimilis and echocardiography
revealed cardiac device-related endocarditis. These cases emphasize the importance of considering endocarditis
in elderly persons having cardiac devices together with the presence of unexplained bacteremia, fever without
focus or persistent fever.
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According the current taxonomy, the beta-hemolytic
streptococci are divided into Lancefield group A strepto-
coccus (S. pyogenes), Lancefield group B streptococcus
(S. agalactiae) and Lancefield group C and G strepto-
cocci (S. dysgalactiae subsp. equisimilis). The spectrum
of S. dysgalactiae subsp. equisimilis diseases ranges from
pharyngitis, tonsillitis and skin and soft-tissue infections
such as wound infections, erysipelas and cellulitis to life-
threatening necrotizing fasciitis and streptococcal toxic
shock syndrome [1]. It can also cause pneumonia, septic
arthritis, osteomyelitis, meningitis, endocarditis, puer-
peral sepsis and bacteremia without focus [1]. Pharyn-
gitis and tonsillitis are the most frequent non-invasive
manifestations of S. dysgalactiae subsp. equisimilis disease.
Cellulitis is the most common clinical manifestation in S.
dysgalactiae subsp. equisimilis bacteremia [1]. This patho-
gen constitutes a major cause of illness in elderly patients
with underlying diseases and skin breakdown [1,2].
During the past twenty years the use of implantable
cardiac devices has increased in the United States [3].
TEE and blood culture are the most important diagnos-
tic tools in cardiac device-related endocarditis. This con-
dition remains a rare but potentially lethal complication
of device implantation [4]. Here we describe two cases of
cardiac device-related endocarditis due to S. dysgalactiae
subsp. equisimilis hospitalized in Tampere University
Hospital. Both patients had recurrent bacteremia of S.
dysgalactiae subsp. equisimilis origin and echocardiog-
raphy revealed cardiac device-related endocarditis. These
two cases emphasize the importance of considering
endocarditis in adults having cardiac devices together




A 79-year-old woman received a dual-chamber pace-
maker for intermittent complete heart block in April
2011. She was on nifedipin 30 mg daily dose for hyper-
tension. She was admitted to the district hospital in
Vammala on January 2013 and diagnosed with S. dys-
galactiae subsp. equisimilis septicemia. The focus of
bacteremia was unknown. On examination she was fe-
verish and presented rubor and swelling in her tender
glenohumeral joint. The arthritis was considered to be
reactive, and no aspiration of joint fluid was made.
She completed a 13-day course of cefuroxime.
In February 2013 she developed recurrent S. dysgalac-
tiae subsp. equisimilis septicemia and was treated in the
district hospital in Vammala. The focus of bacteremia
was still unknown. The only symptom was the articular
pain in the right glenohumeralis joint, this time without
redness or swelling. The electrocardiogram showed sinusrhythm, and there were normal auscultatory findings.
Full-body CT showed pericardial and pleural effusion.
TTE revealed no vegetation. She received a treatment
course of ceftriaxone intravenously for 10 days.
On the 5th of May 2013 she was admitted to Tampere
University Hospital with fever and paresis of the right
radialis nerve. There was a new systolic murmur heard
on the apex. CT of the brain was normal. Two cultures
of blood taken on admission yielded S. dysgalactiae
subsp. equisimilis. Laboratory test results revealed normal
hemoglobin level of 129 g/liter, an elevated leucocyte count
of 14× 109 /liter, and an elevated C-reactive protein
level of 140 mg/liter. TEE revealed a 15 mm long mass
attached to the pacemaker lead on the right atrium
(Figure 1). There was a good cardiac function with ejec-
tion fraction over 60 per cent, and no signs of valvular
vegetations. She was treated with benzylpenicillin at
four million IU six times a day. On 16th of May the pa-
tient underwent successful complete pacemaker removal.
A temporary pacemaker system was implanted due to
intermittent total heart block. Samples from the leads
extracted yielded no growth. She completed a four-week
course of intravenous antibiotics and has subsequently
remained well. A new permanent pacemaker was im-
planted uneventfully on the right side in June 2013.
Case 2
On 30th of July 2013 a 92-year-old man was admitted to
Hatanpää City Hospital with fever and cellulitis of the
arm. He had a prior history of hypertension, paroxysmal
atrial fibrillation, polymyalgia rheumatica and a pros-
thetic knee joint on right side inserted in the year 2008.
A dual-chamber pacemaker was implanted in June 2012
due to total heart block. His regular treatment consisted
of prednisolon 2.5 mg, furosemid 20 mg, nilvadipin
8 mg, aspirin 100 mg, pantopratsol 40 mg, calcium and
vitamin D supplement, magnesium supplement 250 mg,
and gabapentin 900 mg daily doses. Blood culture re-
vealed S. dysgalactiae subsp. equisimilis bacteremia and
he suffered from cellulitis of the arm. He was treated at
Hatanpää City Hospital.
On 30th of September 2013 he was again admitted to
Hatanpää City Hospital. On admission his temperature
was 38.3°C. The serum blood test revealed reduced
hemoglobin level of 91 g/liter, an increased leucocyte
count of 20 × 10 109 /l, and an increased C-reactive pro-
tein level of 302 mg/liter. Two blood cultures taken on
admission were positive for S. dysgalactiae subsp. equisi-
milis. He was diagnosed a recurrent septicemia and cel-
lulitis in the right leg. There were no skin lesions. Initial
treatment with cefuroxime 1.5 g intravenously three
times a day was changed to benzylpenicillin at two mil-
lion IU six times a day (total 12 million IU a day) after
two days.
Figure 1 Transesophageal echocardiography examination of the first patient. The bold arrow points to the two-tailed vegetation in the
right atrium. The vegetation was attached to the pacemaker lead.
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University Hospital, because he had persistent fever. He
suffered from severe pain in his right foot. He was
afebrile but disorientated at arrival, and could not lift
his right leg. Blood pressure on admission was 127/
64 mmHg. On auscultation there were normal heart
sounds. An abdominal CT revealed an abscess in the
psoas region on the left side with maximal diameter of
5.8 cm. The aspiration fluid culture was negative for
bacteria. A chest X-ray showed pericardium effusion. An
echocardiography was performed. The patient appeared
quite ill, and was considered not to be eligible for TEE.
TTE revealed a large vegetation on the ventricular pace-
maker lead. This fluttering mass had diameters of 14 ×
six mm (Figure 2), and was attached to the pacemaker
leads distal end. Pulmonary artery pressure was esti-
mated to 70–75 mmHg, otherwise echocardiograpy re-
sults were normal with good biventricular function and
no signs of valvular lesions. The patient was treated with
benzylpenicillin at four million IU six times a day (total
24 million IU a day) and a 500 mg daily dose of oral
levofloxacin.
This elderly patient was very fragile, and the pace-
maker system was not extracted. He suffered from back
pain and persistent pain in his right buttock. Abdominal
CT revealed spondylodiscitis at the level of L4/5. Ther-
apy was continued with benzylpenicillin at four millionIU six times a day for six weeks intravenously followed
by suppressive treatment with amoksisillin a 500 mg
three times a day.
Conclusion
Cardiac device-related endocarditis is a very rare clinical
manifestation of S. dysgalactiae subsp. equisimilis dis-
ease [1,4]. A thorough search of the literature identified
no published cases of cardiac device-related endocarditis
involving S. dysgalactiae subsp. equisimilis as causative
agents. Staphylococcus aureus is the major infective agent
responsible for 47% of cardiac device-related endocarditis,
followed by coagulase-negative staphylococci (35%), other
gram positive (11%) and gram negative (11%) organisms
[5]. Endocarditis caused by S. dysgalactiae subsp. equisi-
milis is uncommon, accounting for fewer than 1% of
total cases [6].
The use of pacemakers has increased in the last
15 years [7,8]. Likewise the number of elderly persons
with chronic illness is growing. Both case patients were
elderly and S. dysgalactiae subsp. equisimilis bacteremia
usually occurs at high age [9]. In the Pirkanmaa area in
Finland the incidence of S. dysgalactiae subsp. equisimi-
lis bacteremia has increased [10]. These factors might
contribute to the occurrence of rare and serious infec-
tions caused by this bacterium, such as endocarditis.
The second patient was treated with immunosuppressive
Figure 2 Transthoracic echocardiography examintion of the second patient. The slender arrow points to the ventricular pacemaker lead.
The bold arrow points to the fluttering vegetation mass.
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make him prone to rare pathogen. Recurrent bacteremia
is common in S. dysgalactiae subsp. equisimilis bacteremia
[11]. Cellulitis is the most common clinical manifestation
in recurrence [11]. S. dysgalactiae subsp. equisimilis iso-
lates can aggregate human platelets and can internalize
into human endothelial cells and they may both promote
persistence within the vascular system [12]. Rohde and
co-workers have identified a fibronecting-binding protein,
GfbA, from group G streptococci, which functions as an
adhesin and invasin and the invasion mechanism differ
from group A streptococci [13].
A cardiac device -related infection is a life-threatening
complication [5,14]. Blood cultures have an important role
in the diagnostic process of suspected infective endocardi-
tis. During 2013 the BacT/ALERT 3D (bioMérieux SA,
Marcy-L’Etoile, France) blood culture system with stand-
ard culture media was used. In the current cases, the
Lancefield serogroups were defined by latex agglutination
using the Streptex latex test system (Remel Europe Ltd,
Dartford, UK). All isolates were also strain identified by a
commercial test (Rapid ID 32 STREP, bioMérieux SA,
Marcy-1’Etoile, France). Previous studies of permanent
pacemaker lead endocarditis have confirmed the superior-
ity of TEE over TTE [4,15]. Management should consist
in complete device extraction and long-term administra-
tion of antibiotics which cover the pathogen cultured from
blood or samples from leads extracted. Cardiac device-
related endocarditis is associated with a mortality rate of66% if the device is not extracted [14]. In the case of
complete device extraction combined with antimicro-
bial therapy the mortality rate is 13-21% [4,14]. The
optimal timing of re-implantation remains unknown.
Re-implantation should be conducted at a new site.
Most authors think that re-implantation can take place
when the patients are no longer bacteremic [16]. The
duration of antibiotic therapy has varied widely in the
published literature [16-18]. Some authors have sug-
gested that four weeks of therapy should be sufficient
[16]. Several guidelines recommend the addition of
aminoglycoside to penicillin therapy of streptococcal
endocarditis during the first two weeks [19]. Because of
high nephrotoxicity risk for elderly, a narrow-spectrum
monotherapy treatment with benzylpenicillin was pre-
ferred for these patients instead of combination of
benzylpenicillin and gentamicin.
In conclusion, S. dysgalactiae subsp. equisimilis is a
pathogen which very rarely causes cardiac device endo-
carditis. The two cases reported here emphasize the im-
portance of considering endocarditis in elderly persons
having cardiac devices together with the presence of un-
explained bacteremia.
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